FDA Approves Sandoz Biosimilars for Two Blockbuster Amgen Bone Drugs
A blockbuster Amgen antibody that treats bone conditions is set to face its first biosimilar competition. The FDA on Tuesday ...
Friday, November 22, 2024
Tag: Sandoz